Modern Vaccines Adjuvants & Delivery Systems

18-20 May 2015, Leiden University Medical Center, Leiden, The Netherlands

  • Increase font size
  • Default font size
  • Decrease font size

Introduction

The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation/delivery systems for these new vaccines. This new international conference will focus on updating the community on new adjuvant/delivery systems/technologies associated with developing modern vaccines strategies and vaccine research. There is now an urgent need for the development of these potent and safe adjuvants and delivery systems and MVADS 2015 will offer researchers a fresh forum to discuss this important topic in detail.

MVADS 2015 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.

Advisory Scientific Panel

Local Organisers: Edmund J. Remarque (BPRC, Rijswijk, The Netherlands) and Ferry Ossendorp (Leiden University Medical Center, Leiden, The Netherlands)

Dennis Christensen (Statens Serum Institut, Copenhagen, Denmark)
Erik Lindblad (Brenntag Biosector, Copenhagen, Denmark)
Stein Lokstad (Brenntag Biosector, Copenhagen, Denmark)
Rob Lambkin-Williams (Retroscreen Virology Ltd, London, UK)
Heather Davis (Pfizer Vaccine Research, Ottawa, Canada)
Derek O’Hagan (Novartis Vaccines, Cambridge, Massachusetts, USA)
Adriana Baz Morelli (CSL Ltd, Melbourne, Australia)
Ali Harandi (University of Gothenburg, Gothenburg, Sweden)
John Clements (Tulane University, New Orleans, Louisiana, USA)
Gwyn Davies (St. George’s, University of London, UK)
Nathalie Garcon (BIOASTER Technology Research Institute, Lyon, France)
Niranjan Sardesai (Inovio Inc., Plymouth Meeting, Pennsylvania, USA)
Greg Glenn (Novavax Inc., Maryland, USA)
Virgil Schijns (Wageningen Unviversity, The Netherlands)
Gary Ott (Dynavax Inc., San Diego, California, USA)
Burkhard Becher (University of Zurich, Zurich, Switzerland)
Stephane Ascarateil (SEPPIC, Paris, France)
Geert Vanden Bossche (UNIVAC LLC, Belgium)
Steve Reed (IDRI, Seattle, USA)
Martin Bachmann (University of Zurich, Switzerland & University of Oxford, UK)
Anna-Karin Maltais (Eurocine Vaccines AB, Solna, Sweden)
Nicolas Havelange (EVI, Heidelberg, Germany)
Jeffrey A. Hubbell (EPFL, Lausanne, Switzerland)
Behazine Combadiere (Cimi-Paris, Paris, France)

Conference Scope

Scientific Sessions:

  • Mechanistic Interpretations
  • Delivery
  • Formulation & Design
  • Modern Vaccines & Adjuvants
  • Safety
  • Regulation
  • Future Developments
 

MVADS 2015 Delegates

Login details will be supplied after you have registered for the event.

MVADS 2015 Venue


MVADS 2015 Sponsors

  • Bill and Melinda Gates Foundation
  • CSL
  • Dynavax
  • Janssen
  • NatureGeneTherapy.com
  • Mucosis
  • Univac
  • Retroscreen Virology
  • Bioaster
  • CureVac
  • Mymetics
  • National Institute of Allergy and Infectious Diseases
  • European Vaccine Initiative
  • Aldevron
  • Izon
  • Pfizer
  • Seppic
  • DNAvaccine.com
  • Abivax
  • Novartis Vaccines
  • Brenntag
  • BPRC
  • Infectious Disease Research Institute
  • Eurocine Vaccines
  • Sanofi Pasteur
  • BIA Separations
  • Novavax
  • Inovio Pharmaceuticals
  • Vaxart

MVADS 2015 Downloads

MVADS 2015 Leaflet

MVADS 2015 Mailing List

Name
E-mail Address
What is 3+2-1?